These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18757320)

  • 1. Obesity and cancer treatment: weighing the evidence.
    Griggs JJ; Sabel MS
    J Clin Oncol; 2008 Sep; 26(25):4060-2. PubMed ID: 18757320
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives.
    Arcasoy MO
    Clin Cancer Res; 2008 Aug; 14(15):4685-90. PubMed ID: 18676735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Vigneri R; Frasca F; Sciacca L; Vigneri P; Frittitta L
    J Natl Cancer Inst; 2009 Jul; 101(14):1030-1; author reply 1031-2. PubMed ID: 19546433
    [No Abstract]   [Full Text] [Related]  

  • 4. An ideal prognostic test for estrogen receptor-positive breast cancer?
    Paik S; Tang G; Fumagalli D
    J Clin Oncol; 2008 Sep; 26(25):4058-9. PubMed ID: 18678837
    [No Abstract]   [Full Text] [Related]  

  • 5. Clusterin: a potential target for improving response to antiestrogens.
    Toffanin S; Daidone MG; Miodini P; De Cecco L; Gandellini P; Cappelletti V
    Int J Oncol; 2008 Oct; 33(4):791-8. PubMed ID: 18813793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enlarging body of evidence: obesity and chronic kidney disease.
    Chertow GM; Hsu CY; Johansen KL
    J Am Soc Nephrol; 2006 Jun; 17(6):1501-2. PubMed ID: 16672317
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
    Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism in cancer patients.
    Arends J
    Anticancer Res; 2010 May; 30(5):1863-8. PubMed ID: 20592393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of apoptosis-related gene expression in different serum level of insulin-like growth factor-1 in mice breast cancer tissue].
    Tang HB; Ye ZR; Ren YP; Zhang S; Chen GQ; Wu YP
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1018-21. PubMed ID: 19035207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
    Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B
    J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat may fuel breast cancer growth.
    Hede K
    J Natl Cancer Inst; 2008 Mar; 100(5):298-9. PubMed ID: 18314468
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization of pathologic complete response rates in breast cancer treatment.
    Knauer M; Devries A; Wenzl E; Haid A
    Breast Cancer Res Treat; 2008 Jul; 110(2):395-6. PubMed ID: 17851755
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
    Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Different expression of liver-specific insulin-like growth factor I gene in breast cancer; expression with mice].
    Tang HB; Ren YP; Hu Y; Zhu ZY; Shuai YF; Wu YP
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1553-6. PubMed ID: 18956639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical versus surgical interventions for the metabolic complications of obesity in children.
    Dixon JB; Jones K; Dixon M
    Semin Pediatr Surg; 2009 Aug; 18(3):168-75. PubMed ID: 19573759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and treatment of prostate cancer: what is the right dose of Lupron Depot?
    Agarwal N; Fletcher D; Ward J
    Clin Cancer Res; 2007 Jul; 13(13):4027. PubMed ID: 17606739
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight loss in patients with advanced cancer: effects, causes, and potential management.
    Jatoi A
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):45-8. PubMed ID: 18685394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.